Sonoe Yoshida
Hakodate, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Severe upper gastrointestinal involvement in ulcerative colitis successfully treated with sequential therapy using intravenous tacrolimus and upadacitinib: a case report.
Journal: Frontiers in medicine
Published: February 17, 2026
Tenofovir alafenamide prevents HBV reactivation in anticancer/immunosuppression: 24-month multicentre prospective study.
Journal: The Journal of infection
Published: November 21, 2025
Circulating cfDNA CD86 methylation is associated with durable response to atezolizumab-bevacizumab in hepatocellular carcinoma.
Journal: Hepatology international
Published: October 22, 2025
Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort.
Journal: Scientific reports
Published: September 19, 2025
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Hepatology international
Published: April 30, 2025
Cirrhotic Cardiomyopathy: Prevalence and Clinical Impact on Liver Cirrhosis Outcomes.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 02, 2025
Novel desensitization therapy of mesalamine intolerance in patients with ulcerative colitis.
Journal: Gastroenterologia y hepatologia
Published: November 15, 2024
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment.
Journal: Targeted oncology
Published: August 14, 2024
Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC.
Journal: JHEP reports : innovation in hepatology
Published: August 04, 2024
Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 23, 2024
Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC.
Journal: Alimentary pharmacology & therapeutics
Published: June 09, 2024
Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma.
Journal: Frontiers in nutrition
Published: August 04, 2023
Last Updated: 09/26/2026